Todd C. Girolamo
General Counsel, Caladrius Biosciences.
Companies
- PROKIDNEY CORP.General counsel Jul 13, 2022 to now1
- Longeveron Inc.Board member Feb 22, 2022 to Dec 22, 20222
- Caladrius BiosciencesGeneral counsel Nov 8, 2021 to Jan 18, 20223
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- PROKIDNEY CORP. PROK327,713 shares4$476.8K at $1.46Jun 12, 2026
- Caladrius Biosciences LSTA160,827 shares5$172.1K at $1.07Jan 14, 2022
- Longeveron Inc. LGVN5,000 shares6$7.5K at $1.50Feb 25, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 12, 2026Converted 163,857 shares of PROKIDNEY CORP.4
- Jul 31, 2024Converted 81,928 shares of PROKIDNEY CORP.7
- Feb 5, 2024Converted 81,928 shares of PROKIDNEY CORP.8
- Feb 25, 2022Granted 5,000 shares of Longeveron Inc.6
- Jan 14, 2022Shares withheld for tax 2,158 shares at $0.82 of Caladrius Biosciences5
- Jan 13, 2022Shares withheld for tax 2,563 shares at $0.81 of Caladrius Biosciences5
- Jan 11, 2022Shares withheld for tax 4,722 shares at $0.87 of Caladrius Biosciences9
- Jan 10, 2022Shares withheld for tax 17,405 shares at $0.92 of Caladrius Biosciences9
- Jan 10, 2022Granted 129,000 shares of Caladrius Biosciences9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPROKIDNEY CORP., General counsel
- 2SEC EDGARLongeveron Inc., Board member
- 3
- 4
- 5
- 6
- 7SEC EDGARForm 4 filed Aug 2, 2024
- 8SEC EDGARForm 4 filed Feb 6, 2024
- 9SEC EDGARForm 4 filed Jan 12, 2022